Selected article for: "contact tracing and percolation site"

Author: Vir Bannerjee Bulchandani; Saumya Shivam; Sanjay Moudgalya; S L Sondhi
Title: Digital Herd Immunity and COVID-19
  • Document date: 2020_4_18
  • ID: k8xuv5xy_28
    Snippet: By contrast, the non-local structure of recursive contact tracing, as illustrated in Fig. 1 , suggests that the universality class of the immune-to-epidemic transition for φ > 0 is distinct from standard site percolation. Nevertheless, in Appendix A we show that for a population without asymptomatic infections (the line θ = 0 in our phase diagram), we can obtain the critical fraction φ c of app usage exactly, for general values of R 0 , such t.....
    Document: By contrast, the non-local structure of recursive contact tracing, as illustrated in Fig. 1 , suggests that the universality class of the immune-to-epidemic transition for φ > 0 is distinct from standard site percolation. Nevertheless, in Appendix A we show that for a population without asymptomatic infections (the line θ = 0 in our phase diagram), we can obtain the critical fraction φ c of app usage exactly, for general values of R 0 , such that an epidemic occurs for φ ≤ φ c and is suppressed for φ > φ c . The calculation proceeds by self-consistently estimating the probability of formation of infinitely long chains of infections, mirroring the standard techniques of percolation theory [22] . In the presence of a finite fraction of asymptomatic people (θ = 0), we rely on a mean-field estimate for the location of the critical line (φ, θ c (φ)) as a function of R S ; detailed studies of the exact location of critical line and the universal features of the contacttracing phase transition are left to future work.

    Search related documents:
    Co phrase search for related documents
    • asymptomatic infection and detailed study: 1
    • asymptomatic people and contact tracing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • contact tracing and critical fraction: 1
    • contact tracing and critical line: 1
    • contact tracing and detailed study: 1, 2, 3
    • contact tracing and epidemic immune: 1, 2, 3
    • contact tracing and epidemic immune transition: 1, 2